Ysios Capital is a leading Spanish venture capital firm providing funding to highly innovative life sciences companies developing therapies for diseases with significant unmet medical needs. With offices in San Sebastián and Barcelona, the firm has a diverse team of professionals dedicated to transforming capital into medical breakthroughs, delivering both attractive financial returns and a positive societal impact. Founded in 2008, Ysios Capital manages more than €400 million in assets across three funds. The firm also plays an active role in fostering the biotechnology ecosystem through initiatives such as InceptionBio, its new strategic vertical focused on company creation and early-stage projects. In addition, Ysios Capital serves as investment advisor to the listed Telescope Biotech Fund, which is managed by Andbank Wealth Management (https://andbank.es/boutiquehub/ysios/).
Looking for a particular Ysios Capital employee's phone or email?
Ysios Capital Questions
The Ysios Capital annual revenue was $5.3 million in 2026.
Iñigo Anitua is the CFO of Ysios Capital.
17 people are employed at Ysios Capital.
Ysios Capital is based in Barcelona, Catalonia.
The NAICS codes for Ysios Capital are [54, 5417, 54171, 541, 541713].
The SIC codes for Ysios Capital are [873, 87].
Top Ysios Capital Employees
-
Iñigo Anitua
Chief Financial Officer at Ysios Capital
Bilbao, PV, ES12 -
Julia Salaverria
Managing Partner at Ysios Capital
San Sebastián, PV, ES14 -
Arturo Urrios
Partner at Ysios Capital
Barcelona, CT, ES2 -
Jordi Xiol
Partner at Ysios Capital
Barcelona, CT, ES2 -
Raúl Martín-Ruiz
Partner at Ysios Capital
Madrid, ES22 -
Karen Wagner
General Partner at Ysios Capital
Switzerland23 -
Wen Cheng
General Counsel and Head of ESG at Ysios Capital
Barcelona, CT, ES2 -
María Vega de Seoane Moreno
Financial Controller at Ysios Capital
San Sebastián, PV, ES2
Related Companies
